Grove Bank & Trust’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-79
Closed -$3.59K 614
2023
Q3
$3.59K Buy
+79
New +$3.59K ﹤0.01% 602